azomycin has been researched along with bromodeoxyuridine in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (37.50) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 5 (31.25) | 29.6817 |
| 2010's | 2 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gray, P; Stratford, IJ | 1 |
| Phillips, TL | 1 |
| Munzenrider, JE | 1 |
| Coleman, CN | 1 |
| Geard, CR; Rutledge-Freeman, MH; Spunberg, JJ | 1 |
| Hodgkiss, RJ; Webster, L; Wilson, GD | 2 |
| Durand, RE; Raleigh, JA | 1 |
| Bussink, J; Heerschap, A; Lok, J; Punt, CJ; van Der Kogel, AJ; van Laarhoven, HW | 1 |
| Sanders, PW; Wang, PX | 1 |
| Campa, J; Carlin, S; Humm, JL; Larson, SM; Ling, CC; Pugachev, A; Ruan, S | 1 |
| Bixby, LM; Bustamante, JM; Tarleton, RL | 1 |
| Fujibayashi, Y; Fujieda, S; Furukawa, T; Kobayashi, M; Kudo, T; Mori, T; Oh, M; Tanaka, T | 1 |
| Civelek, AC; Huang, T; Jiang, H; Li, J; Li, XF; Ng, CK; Postel, GC; Shen, B | 1 |
| Baumann, M; Brüchner, K; Gurtner, K; Helbig, L; Hess-Stumpp, H; Koi, L; Pruschy, M; Unterschemmann, K; Yaromina, A; Zips, D | 1 |
4 review(s) available for azomycin and bromodeoxyuridine
| Article | Year |
|---|---|
Radiation sensitizers.
Topics: Animals; Antineoplastic Agents; Bromodeoxycytidine; Bromodeoxyuridine; Carcinoma; Deoxyuridine; Dogs; Dose-Response Relationship, Radiation; Floxuridine; Humans; Hypoxia; Idoxuridine; Lung Neoplasms; Methotrexate; Metronidazole; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Nitroimidazoles; Radiation-Sensitizing Agents; Research; Sarcoma, Experimental; Skin | 1976 |
Chemical modification of radiation effects.
Topics: Animals; Antineoplastic Agents; Bromodeoxyuridine; Cell Survival; Cysteamine; DNA; Drug Evaluation; Drug Interactions; Humans; Hypoxia; Metronidazole; Neoplasms; Neoplasms, Experimental; Nitroimidazoles; Radiation Effects; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1977 |
Recent advances in radiotherapy.
Topics: Breast Neoplasms; Bromodeoxyuridine; Carcinoid Tumor; Elementary Particles; Fast Neutrons; Hot Temperature; Humans; Male; Melanoma; Metronidazole; Neoplasms; Nitroimidazoles; Pancreatic Neoplasms; Prostatic Neoplasms; Protons; Radiation Protection; Radiation Tolerance; Radiation-Sensitizing Agents; Radioisotopes; Radiotherapy Dosage; Radiotherapy, High-Energy; Rectal Neoplasms; Salivary Gland Neoplasms; Sarcoma; Soft Tissue Neoplasms | 1977 |
Modification of radiotherapy by radiosensitizers and cancer chemotherapy agents. I. Radiosensitizers.
Topics: Antineoplastic Agents; Bromodeoxyuridine; Combined Modality Therapy; Glutathione; Humans; Idoxuridine; Interleukin-1; Neoplasms; Nitroimidazoles; Oxidation-Reduction; Oxygen; Radiation-Protective Agents; Radiation-Sensitizing Agents | 1989 |
12 other study(ies) available for azomycin and bromodeoxyuridine
| Article | Year |
|---|---|
Some factors affecting the specific toxicity of misonidazole towards hypoxic mammalian cells.
Topics: Blood; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 1978 |
A comparison of the cytological effects of three hypoxic cell radiosensitizers.
Topics: Animals; Bromodeoxyuridine; Cell Cycle; Cell Line; Cell Survival; Cricetinae; Cricetulus; Dose-Response Relationship, Drug; Etanidazole; Lung; Misonidazole; Nitroimidazoles; Radiation-Sensitizing Agents; Sister Chromatid Exchange | 1982 |
Simultaneous triple staining for hypoxia, proliferation, and DNA content in murine tumours.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Hypoxia; DNA, Neoplasm; Flow Cytometry; Immunohistochemistry; Male; Mice; Mice, Inbred CBA; Neoplasms, Experimental; Nitroimidazoles; Predictive Value of Tests; S Phase; Staining and Labeling; Theophylline; Tumor Cells, Cultured | 1995 |
Cell cycle distribution of hypoxia and progression of hypoxic tumour cells in vivo.
Topics: Adenocarcinoma; Animals; Bromodeoxyuridine; Cell Cycle; Cell Division; DNA, Neoplasm; Flow Cytometry; Hypoxia; Mice; Neoplasms, Experimental; Nitroimidazoles; Sarcoma, Experimental; Theophylline | 1998 |
Identification of nonproliferating but viable hypoxic tumor cells in vivo.
Topics: Animals; Bromodeoxyuridine; Cell Division; Cell Hypoxia; Cell Separation; Flow Cytometry; Humans; Mice; Mice, SCID; Neoplasms; Nitroimidazoles; Radiation-Sensitizing Agents; Transplantation, Heterologous; Tumor Cells, Cultured | 1998 |
Effects of nicotinamide and carbogen in different murine colon carcinomas: immunohistochemical analysis of vascular architecture and microenvironmental parameters.
Topics: Animals; Benzimidazoles; Bromodeoxyuridine; Carbon Dioxide; Cell Hypoxia; Cell Line, Tumor; Colonic Neoplasms; Female; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Niacinamide; Nitroimidazoles; Oxygen; Radiation-Sensitizing Agents | 2004 |
Mechanism of hypertensive nephropathy in the Dahl/Rapp rat: a primary disorder of vascular smooth muscle.
Topics: Animals; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Hypertension; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Male; Muscle, Smooth, Vascular; Nitroimidazoles; Rats; Rats, Inbred Dahl; Renal Insufficiency; Sodium Chloride; Sucrose; Time Factors; Transcription Factors | 2005 |
Dependence of FDG uptake on tumor microenvironment.
Topics: Animals; Autoradiography; Benzimidazoles; Bromodeoxyuridine; Cell Hypoxia; Cell Proliferation; Coloring Agents; Fluorodeoxyglucose F18; Glucose; Male; Mice; Mice, Nude; Neoplasms; Nitroimidazoles; Prostatic Neoplasms; Radiopharmaceuticals | 2005 |
Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease.
Topics: Animals; Bromodeoxyuridine; CD8-Positive T-Lymphocytes; Chagas Disease; Immunologic Memory; Immunophenotyping; Mice; Nitroimidazoles; Receptors, Chemokine; Treatment Outcome; Trypanosoma cruzi | 2008 |
Radio-copper-labeled Cu-ATSM: an indicator of quiescent but clonogenic cells under mild hypoxia in a Lewis lung carcinoma model.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Carcinoma, Lewis Lung; Cell Proliferation; Colony-Forming Units Assay; Coordination Complexes; Copper Radioisotopes; Disease Models, Animal; Fluorodeoxyglucose F18; Hypoxia; Image Processing, Computer-Assisted; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Staining and Labeling; Thiosemicarbazones | 2009 |
Tumor microenvironment-dependent 18F-FDG, 18F-fluorothymidine, and 18F-misonidazole uptake: a pilot study in mouse models of human non-small cell lung cancer.
Topics: Animals; Biological Transport; Bromodeoxyuridine; Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Dideoxynucleosides; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Lung Neoplasms; Mice; Misonidazole; Necrosis; Nitroimidazoles; Pilot Projects; Positron-Emission Tomography; Radioactive Tracers; Tumor Microenvironment | 2012 |
Hypoxia-inducible factor pathway inhibition resolves tumor hypoxia and improves local tumor control after single-dose irradiation.
Topics: Amines; Animals; Bromodeoxyuridine; Carcinoma, Squamous Cell; Cell Hypoxia; Cell Nucleus; Dose Fractionation, Radiation; Electron Transport Complex I; Female; Heterografts; Humans; Hypoxia-Inducible Factor 1; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Random Allocation; Tumor Microenvironment | 2014 |